Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study
- PMID: 22106869
- DOI: 10.1111/j.1526-4610.2011.02046.x
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study
Abstract
Background: The Headache Impact Test-6 (HIT-6) has been demonstrated to be a reliable and valid measure that assesses the impact of headaches on the lives of persons with migraine. Originally used in studies of episodic migraine (EM), HIT-6 is finding increasing applications in chronic migraine (CM) research.
Objectives: (1) To examine the headache-impact on persons with migraine (EM and CM) using HIT-6 in a large population sample; (2) to identify predictors of headache-impact in this sample; (3) to assess the magnitude of effect for significant predictors of headache-impact in this sample.
Methods: The American Migraine Prevalence and Prevention study is a longitudinal, population-based study that collected data from persons with severe headache from 2004 to 2009 through annual, mailed surveys. Respondents to the 2009 survey who met International Classification of Headache Disorders 2 criteria for migraine reported at least 1 headache in the preceding year, and completed the HIT-6 questionnaire were included in the present analysis. Persons with migraine were categorized as EM (average <15 headache days per month) or CM (average ≥15 headache days per month). Predictors of headache-impact examined include: sociodemographics; headache days per month; a composite migraine symptom severity score (MSS); an average pain severity rating during the most recent long-duration headache; depression; and anxiety. HIT-6 scores were analyzed both as continuous sum scores and using the standard, validated categories: no impact; some impact; substantial impact; and severe impact. Group contrasts were based on descriptive statistics along with linear regression models. Multiple imputation techniques were used to manage missing data.
Results: There were 7169 eligible respondents (CM = 373, EM = 6554). HIT-6 scores were normally distributed. After converting sum HIT-6 scores to the standard categories, those with CM were significantly more likely to experience "severe" headache impact (72.9% vs 42.3%) and had higher odds of greater adverse headache impact compared with persons with EM (OR = 3.5, 95% CI = 2.77-4.41, P < .0001). Significant predictors of adverse headache impact in both groups included younger age, higher MSS score, higher average long-duration headache pain severity rating, and depression. Lower annual household income, anxiety, and higher standardized headache day frequency predicted adverse headache impact in EM but not CM. With few exceptions, gender, race, and body mass index did not significantly predict adverse headache impact. Finally, rates of depression were more than double among persons with CM (CM = 25.2%, EM = 10.0%), and rates of anxiety were nearly triple (CM = 23.6%, EM = 8.5%).
Conclusions: This work further establishes HIT-6 as a useful instrument for characterizing CM and understanding the increased disease related burden. Persons with CM had significantly higher odds of greater adverse headache impact, when compared with EM. Predictors of greater headache impact for both groups included higher MSS scores, higher average headache pain severity, and depression. Additional predictors unique to EM included higher average household income, younger age, higher standardized headache day frequency, and anxiety. This finding may be related to differences in sample size and power. Further exploration is warranted.
© 2011 American Headache Society.
Similar articles
-
Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.Headache. 2014 May;54(5):830-49. doi: 10.1111/head.12332. Epub 2014 Apr 17. Headache. 2014. PMID: 24527745
-
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19. Headache. 2012. PMID: 21929662
-
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.Value Health. 2013 Jan-Feb;16(1):31-8. doi: 10.1016/j.jval.2012.08.2212. Value Health. 2013. PMID: 23337213
-
[Anxiety and depression in children and adolescents with migraine: a review of the literature].Encephale. 2008 Oct;34(5):504-10. doi: 10.1016/j.encep.2007.08.005. Epub 2007 Dec 26. Encephale. 2008. PMID: 19068340 Review. French.
-
The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074. Epub 2013 Mar 7. Headache. 2013. PMID: 23470015 Review.
Cited by
-
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.J Headache Pain. 2024 Apr 18;25(1):59. doi: 10.1186/s10194-024-01749-8. J Headache Pain. 2024. PMID: 38637754 Free PMC article.
-
Efficacy of migraine prophylaxis treatments for treatment-naïve patients and those with prior treatment failure: a protocol for systematic review and network meta-analysis of randomised controlled trials.BMJ Open. 2024 Mar 1;14(3):e077916. doi: 10.1136/bmjopen-2023-077916. BMJ Open. 2024. PMID: 38431293 Free PMC article.
-
Disease-Related Factors Associated with Acupuncture Response in Patients with Chronic Tension-Type Headache: A Secondary Analysis of A Randomized Controlled Trial.Chin J Integr Med. 2024 Jan 11. doi: 10.1007/s11655-023-3615-2. Online ahead of print. Chin J Integr Med. 2024. PMID: 38206534
-
The Headache Psychologists' Role in Pediatric and Adult Headache Care: A Qualitative Study of Expert Practitioners.J Clin Psychol Med Settings. 2024 Jun;31(2):359-367. doi: 10.1007/s10880-023-09972-2. Epub 2023 Oct 15. J Clin Psychol Med Settings. 2024. PMID: 37839060 Free PMC article.
-
Economic burden of chronic migraine in OECD countries: a systematic review.Health Econ Rev. 2023 Sep 1;13(1):43. doi: 10.1186/s13561-023-00459-2. Health Econ Rev. 2023. PMID: 37656228 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous